Loading…
Lobbying Spend
—
Filings
8
Firms Hired
1
Active Period
2008–2009
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: S.525
Pharmaceutical Market Access Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: S.80
Pharmaceutical Market Access Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: S.80
Pharmaceutical Market Access Act of 2009
2009 · second_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: —
Matched citations: S.80
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: S.525
Pharmaceutical Market Access Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: S.80
Pharmaceutical Market Access Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: S.80
Pharmaceutical Market Access Act of 2009
2009 · first_quarter · Firm: CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS)
Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525
Client expense: — · Firm income: $10,000
Matched citations: S.80
Source: Senate LDA